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of Tennessee Health Science Center, Knoxville, TennesseeABSTRACT In several neurodegenerative disorders, including Huntington’s disease, aspects concerning the earliest of
protein structures that form along the aggregation pathway have increasingly gained attention because these particular species
are likely to be neurotoxic. We used time-resolved small-angle neutron scattering to probe in solution these transient structures
formed by peptides having the N-terminal sequence context of mutant huntingtin exon 1. We obtained snapshots of the formed
aggregates as the kinetic reaction ensued to yield quantitative information on their size and mass. At the early stage, small
precursor species with an initial radius of gyration of 16.15 5.9 A˚ and average mass of a dimer to trimer were monitored. Struc-
tural growth was treated as two modes with a transition from three-dimensional early aggregate formation to two-dimensional
fibril growth and association. Our small-angle neutron scattering results on the internal structure of the mature fibrils demonstrate
loose packing with ~1 peptide per 4.75 A˚ b-sheet repeat distance, which is shown to be quantitatively consistent with a b-helix
model. This research provides what we believe to be new insights into the structures forming along the pathway of huntingtin
exon 1 aggregation and should assist in determining the role that precursors play in neuronal toxicity.INTRODUCTIONCognitive deficits and psychiatric symptoms associated with
random, jerky, and uncontrollable movements are character-
istics of Huntington’s disease (HD), a fatal late-onset auto-
somal polyglutamine (polyQ) neurodegenerative disorder.
Examination of patients’ brains shows region-specific
neuronal degeneration with severe cortical-striatal atrophy.
Similar to other polyQ disorders (1), HD is linked to the
presence of an abnormally long sequence of glutamine
repeats (Q > 36) in the disease protein. The involved
protein, huntingtin (Htt), contains ~3144 amino acids corre-
sponding to the expression of the 67 exons of the HTT gene
(2). However, only the first exon with the polyQ stretch
seems to be required to reproduce HD pathogenesis in cell
and animal models (3).
Recent work shows that cleavage of the full Htt protein
releasing a proteolytic fragment containing exon 1 is an oblig-
atory step to initiate cellular toxicity (4,5). This cleaved frag-
ment containing the expanded polyQ region has a strong
tendency tomisfold toward a stable three-dimensional confor-
mation enriched in b-sheet structure with self-assembly re-
sulting in fibrillar aggregates. Although the link with polyQ
length, aggregation, and disease is inescapable—the longer
the polyQ repeat, the earlier the age of onset and the more
severe the symptoms—numerous studies in HD cell and
animal models show a strong dichotomy between aggregate
presence and neuronal toxicity (6–8). Some results even imply
that aggregates are, in fact, beneficial for neuronal survival.
To address the question ‘‘what makes an aggregate
toxic?’’ an increasing number of reports in the amyloid fieldSubmitted February 10, 2011, and accepted for publication April 8, 2011.
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nism of aggregation implicated in a variety of neurodegen-
erative diseases, including Alzheimer’s and Parkinson’s
diseases, and in which the importance of protein oligomer-
ization in pathogenesis has been emphasized (9).
Various biophysical methods, including atomic force
microscopy (AFM) (10,11) and analytical ultracentrifuga-
tion (12), have been applied toward the identification and
structural characterization of early oligomers formed during
Htt fibrillization with the smallest structures detected being
spherical oligomers of 50 A˚ diameter (10). Small-angle
neutron and x-ray scattering have been efficiently applied
to various aggregation systems including amyloid-b fibrils
(13–16). Here, we utilize small-angle neutron scattering
(SANS) in a time-resolved fashion to pinpoint the various
transient intermediates that form along the aggregation
pathway for a truncated mutant Htt exon 1 peptide. This
peptide contains the 17 N-terminal residues of Htt followed
by a 42-glutamine repeat, a 10-proline stretch, and two
lysines on the C-terminus for enhanced solubility
(NtQ42P10 for short). With SANS, the structures of biolog-
ical macromolecules can be directly measured in solution
without radiation degradation. We are reporting what we
believe to be new quantitative and detailed structural infor-
mation on the aggregation of NtQ42P10 by monitoring the
growth of early-formed species into eventual fibrils.MATERIALS AND METHODS
Materials
The peptide with sequence MATLEKLMKAFESLKSFQ42P10K2
(NtQ42P10) and molecular mass 8583 Da was synthesized by solid-phase
Fmoc chemistry (performed at the Keck-Yale facility, New Haven, CT)doi: 10.1016/j.bpj.2011.04.022
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raphy (HPLC). Mass spectrometry confirmed the purified peptide contained
42 glutamines. Trifluoroacetic acid (TFA) (>99.5%; Thermo Fisher
Scientific, Waltham, MA), 1,1,1,3,3,3-hexafluoro-2-isopropanol (HFIP)
(99.5þ%; Acros Organics, Geel, Belgium), 10 phosphate-buffered saline
(PBS) powder (Thermo Fisher Scientific), and D2O (99.9% D, Cambridge
Isotope Laboratories, Andover, MA) were used without further purification.Peptide solubilization and disaggregation
The NtQ42P10 peptide was solubilized and disaggregated similar to estab-
lished procedures (17). Briefly, the purified peptide was dissolved in
50:50 TFA/HFIP, incubated for 3 h, and then dried under Argon gas. For
HPLC kinetics, the peptide was first solubilized into 0.05% TFA D2O,
ultracentrifuged at 356k  g at 4C for 2 h, and the supernatant brought
up to 1 PBS D2O to initiate the reaction.High performance liquid chromatography
A model No. 1100 series HPLC equipped with a C3 column (Agilent Tech-
nologies, Santa Rosa, CA) was used with a reverse phase water (þ 0.05%
TFA) / acetonitrile (þ 0.05% TFA) gradient. The peptide concentration was
determined by HPLC using a standard curve generated from NtQ22P10
peptide (same sequence as NtQ42P10 but with 22 glutamines) and amino-
acid analysis. To overcome the 40-min HPLC runtime per sample,
NtQ42P10 aliquots removed from the reaction vessel were quench-frozen
in liquid nitrogen and stored at –80C. The time-point aliquots were then
individually thawed, ultracentrifuged at 356k  g at 4C for 20 min, and
supernatant injected onto the HPLC for monomer concentration
measurement.Thioflavin T fluorescence
The fluorescence of Thioflavin T (ThT) was monitored using a model No.
LS 55 fluorescence spectrometer (Perkin-Elmer, Waltham, MA) with exci-
tation and emission wavelengths, lex ¼ 450 nm and lem ¼ 482 nm, respec-
tively. Sample aliquots of 20 mL were removed from the reaction vessel,
diluted with 130 mL 1 PBS, and then 5 mL of 2 mM ThT solution was
added to give 64.5 mM ThT final. Equivalent background runs of ThT in
1 PBS were performed and subtracted from the sample signal.Congo Red birefringence
An aliquot of the NtQ42P10 fibril sample grown in 1 PBS D2O and
measured by SANS was placed on a microscope slide and dried at 37C
overnight. The sample was fixed with 10% formalin, rinsed with deionized
water, stained with 1% Congo Red solution for 30 min at room temperature,
rinsed again with deionized water, and then mounted with a coverslip after
drying. Images were collected using a microscope (40; Leica, Solms,
Germany) and cross-polarizers.Transmission electron microscopy
Transmission electron microscopy (TEM) was performed using a model
No. H-600 electron microscope (Hitachi, Tokyo, Japan) in the Biological
Sciences Division, University of Tennessee. Aliquots of the NtQ42P10 fibril
sample grown in 1 PBS D2O and measured by SANS were fixed to collo-
dion/carbon grids and stained with a 1% uranyl acetate solution for
imaging. Single fibril diameter was measured at 21 different positions on
the TEM image using the software program ImageJ (18) and converted
from pixels to nanometers using the image scale bar. The fibril radius in
A˚ngstroms was then calculated to directly compare with the SANS results.Small-angle neutron scattering
SANS experiments were performed on the CG-3 Bio-SANS instrument at
the High Flux Isotope Reactor at Oak Ridge National Laboratory (Oak
Ridge, TN). Neutrons of wavelength, l ¼ 6.0 A˚ with a wavelength spread,
Dl/l ¼ 0.14 were used. Time-resolved measurements were made with
a 6.9 m sample/detector distance with static sample measurements also
made at 1.2 and 15.4 m to obtain data at higher and lower respective wave-
vector transfer, Q ¼ 4p sin(q)/l, where 2q is the scattering angle. Samples
were loaded into 2 mm pathlength rectangular-shaped quartz cuvettes
(Hellma USA, Plainville, NY).
For the time-resolved measurements, 15-min neutron exposure intervals
were collected where structural changes taking place over this time were
integrated to reflect the average structure. Samples with sedimenting aggre-
gates were dispersed by inverting the cuvette several times to ensure sample
homogeneity and then measured for 15 min. It was found that no significant
sample settling occurred over this timeframe as gauged by comparing the
total integrated intensity on the detector for consecutive 5-min exposures.
For static measurements on NtQ42P10 fibrils, 0.5, 1, and 2 h exposure times
were collected at 1.2, 6.9, and 15.4 m, respectively. These longer exposure
times were achieved by binning multiple 15-min exposures obtained upon
first dispersing the sample to homogeneity. Scattered neutrons were de-
tected with a 1  1 m two-dimensional position-sensitive detector with
192  192 pixels.
NtQ42P10 was solubilized and disaggregated following the above proce-
dures except the Argon-dried film was resuspended first in 0.05% TFA D2O
to dissolve the peptide, brought up in PBS D2O, and then centrifuged at
16.1k  g for 2 min to remove any particulates. The NtQ42P10 fibril sample
was prepared in the same manner and allowed to aggregate for >500 h at
22C before measurement. The final NtQ42P10 concentration was deter-
mined by HPLC to be 0.93 mg/mL (108 mM) in PBS D2O for the kinetics
sample and 0.76 mg/mL (89 mM) for the fibril sample. All neutron scat-
tering experiments were conducted at 20C.
Data reduction was accomplished using IgorPro software (WaveMetrics,
Lake Oswego, OR) with SANS macros developed by Dr. Ken Littrell (Oak
Ridge National Laboratory). The total two-dimensional scattering was cor-
rected for the scattering from the quartz cell and from stray neutrons in the
room and for nonuniform detector response. Then, the scattering was
normalized by the incident beam flux, radially averaged to obtain I(Q)
versus Q, and then I(Q) was placed on absolute scale intensity using porasil
B as a calibration standard with known scattering cross section. Background
scattering from the buffer, Ibg(Q), and the Q-independent excess incoherent
scattering, Iinc(0), were subtracted from the total scattering, Itot(Q), to
obtain the protein sample scattering, IsamðQÞ ¼ ItotðQÞ  IbgðQÞ  Iincð0Þ,
with Iinc(0) determined fromQ> 0.35 A˚
, assuming the residual difference
in intensity is completely incoherent scattering.
Fitting procedures for the SANS data followed a Guinier analysis (19).
Within the Guinier regime, with the low-Q region of the scattering profile
where Qmax$Rg % 1.3, the scattering intensity can be described as
IðQÞ ¼ Ið0Þ exp  Q2R2g=3; (1)
with
Ið0Þ ¼ cM
NA
ðDrÞ2 y2: (2)
The value M was calculated from I(0) ¼ scattering intensity at zero angle,
where c¼ peptide concentration, Dr¼ contrast in scattering length density
between protein and D2O buffer solution (¼ rprot – rbuf), y¼ protein partial
specific volume (¼ 0.73 mL/g), and NA ¼ Avogadro’s number. The peptide
scattering length density, rprot ¼ 3.564  1010 cm2 was calculated from
the atomic composition using the program CRYSON (20) that accounts
for H/D exchange. The D2O scattering length density used was rD2O ¼
6.404  1010 cm2.Biophysical Journal 100(10) 2504–2512
2506 Stanley et al.Modified Guinier fits were made by plotting ln[Q$I(Q)] versus Q2 to
obtain the slope ¼ R2c=2, where Rc is the cross-sectional radius of gyration
and related to the cylindrical radius by R ¼ ﬃﬃﬃ2p Rc. Then, from the intercept
(Ic(0)), the mass per length was calculated
ML ¼ Icð0ÞNA
pcðDrÞ2 y2: (3)
Values for rprot, rbuf, and y were the same as above.FIGURE 1 Aggregation kinetics of NtQ42P10 and the resulting fibrils. (A)
Disappearance of monomeric NtQ42P10 (93 mM) from the supernatant solu-
tion (solid circles) and increasing ThT fluorescence (open circles) corre-
sponding to the formation of ThT-binding amyloidlike aggregates. (Solid
lines) Single-exponential fits to the data with an extrapolation of the ThT
fluorescence fit (dashed line). (B) NtQ42P10 fibrils stained with Congo
Red exhibit birefringence by polarizing optical microscopy (scale bar ¼
50 mm), which is indicative of amyloidlike aggregates. (C) TEM image
of the fibrils formed by NtQ42P10 with a calculated fibril radius, R ¼
40 5 8 A˚ and range of 28–56 A˚.RESULTS AND DISCUSSION
NtQ42P10 aggregates formed at high
concentration are amyloidlike
Using equivalent conditions to our SANS experiments,
which require peptide concentrations in the mg/mL range,
we performed kinetic studies on NtQ42P10 aggregation
with 93 mM monomer in phosphate-buffered saline (PBS)
D2O at 22
C. Monomer disappearance was followed by
reverse phase HPLC and fibril production monitored by
the fluorescence of ThT, an amyloidophilic dye. Fig. 1 A
shows that the aggregation reaction proceeds rapidly with
the amount of soluble monomer decreasing in the absence
of a noticeable lag phase and a single exponential rate
constant kmon ¼ 1.28 5 0.09 h1. Only 10% monomer re-
mained in solution after 2 h and was completely consumed
by 6.5 h. Concurrently, the ThT fluorescence signal, indica-
tive of the presence of amyloidlike structures, also lacks an
observable lag phase and reaches a plateau at ~2 h with an
exponential rate constant kfib ¼ 1.1 5 0.3 h1 similar to
kmon (Fig. 1 A).
The inverse dependence of the lag phase duration on
monomer concentration is a phenomenon already known
from other amyloid proteins (21), and an observed lag phase
recently was reported for a F17W mutant NtQ30P6 peptide
(22). Once formed, the NtQ42P10 aggregates were character-
ized by Congo Red birefringence and TEM. Aggregates
stained with Congo Red and viewed by polarized light
microscopy display a gold/apple-green birefringence char-
acteristic of amyloidlike fibrils (Fig. 1 B). Likewise, TEM
shows the fibrillar nature of the NtQ42P10 aggregates
(Fig. 1 C), where both individual fibrils and fibril bundles
were observed. The radii of individual fibrils range from
28 to 56 A˚ with an average radius of R ¼ 405 8 A˚.
The substitution of D2O for H2O can influence protein
aggregation processes (16,23). For the kinetic assays per-
formed above, we did not observe any dramatic difference
in the aggregation rate for D2O compared to H2O and found
the resulting fibrils to have the same structure as those
grown in H2O within the resolution of TEM (data not
shown). Their similarity also can be assessed by comparing
the aggregates in Fig. 1 C with TEM of NtQ30P6 fibrils
grown in H2O (22). In summary, we find that NtQ42P10
aggregation at high monomer concentrations in D2O buffer
does not drastically affect the amyloid properties of theBiophysical Journal 100(10) 2504–2512resulting fibrils, only the kinetics of formation—namely,
leading to faster aggregation rates and shortened lag phase
times in the ThT assay.Quantifying the NtQ42P10 aggregates by SANS
With the scattering vector range chosen for the time-
resolved SANS measurements, 0.01 < Q < 0.1 A˚1, we
monitored size changes that occur from hundreds down to
tens of A˚ngstroms, respectively. To optimize the time-
resolved measurements for sample kinetic rate, data
binning, and instrumental signal/noise, we first performed
several experiments at different starting monomer concen-
trations and varied the neutron exposure time binning.
From these initial experiments, we confirmed reproduc-
ibility and the direct dependence of the kinetic rate on
peptide concentration. We also found that 15-min neutron
Huntingtin Aggregates Probed by SANS 2507exposures and 50–100 mM NtQ42P10 provide a sufficient
balance between time resolution and SANS signal/noise
ratio for adequately following structural changes in time.
Therefore, after 11 min to load NtQ42P10 into the instru-
ment and acquire a transmission measurement, time-
resolved SANS profiles were acquired every 15 min.
Fig. 2 A shows selected SANS profiles that illustrate how
the scattering intensity (I(Q)) increases and changes shape
over the time-course of the aggregation reaction. Changes
in the shape of the scattering profiles are emphasized
in the Kratky plot representation, Q2$I(Q) versus Q
(Fig. 2 A, inset), which correspond to changes in overall
aggregate structure. The formation of a maximum at Q z
0.03 A˚1 in the Kratky plot reveals a conformational transi-
tion over time toward increased folding with greater struc-
tural rigidity.
Guinier analysis (see Materials and Methods) (19) was
applied to each of the radially averaged SANS profiles by
plotting ln[I(Q)] versus Q2 to obtain quantitative informa-
tion on the size (via the radius of gyration, Rg) and oligomer-
ization state (via the apparent molecular mass, M) of0.01
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FIGURE 2 Time-resolved SANS on NtQ42P10 and analysis. Peptide
concentration was 108 mM. (A) Select time-resolved SANS profiles, I(Q)
versus Q, of NtQ42P10 at 26 (blue), 56 (green), 86 (yellow), and
1083 min (red). Kratky plots, Q2$I(Q) versus Q (inset, colors correspond
to the same times in the main plot, error bars omitted for clarity) show
the formation of a maximum aboutQz 0.03 A˚1 with time, which is indic-
ative of an increase in folding and structural rigidity. (B) A representative
Guinier plot and fits to the SANS curve for 26 min. (C) A representative
modified Guinier plot and fits to the SANS curve for 86 min. (Error
bars) Standard errors from the radial average of the intensity data on the
neutron area detector.NtQ42P10. Fig. 2 B displays a representative Guinier plot
to the SANS curve obtained at 26 min (¼ 11 min þ
15 min), where obtained linear fits within Qmax$Rg % 1.3
correspond to slope ¼ R2g/3. We found two linear fit
regions—a proper one (Qmax$Rg,1 ¼ 1.06) corresponding
to a distinct population of small species (Rg,1 ¼ 16.1 5
5.9 A˚) and a second approximate one (Qmax$Rg,2 ¼ 1.46)
that is indicative of larger species with Rg,2 ¼ 57 5 24 A˚.
The dimensions obtained for the larger aggregates were
affected by additional influences including polydispersity
and favorable interactions between smaller species. The
continuous upturn in the Guinier plot at small Q also indi-
cates the presence of aggregates larger than the Q-range
of the instrument configuration.
Eventually, during the course of aggregation, the
increasing anisotropy of the forming fibrils resulted in the
fibril length exceeding our SANS measurements such that
only the two-dimensional fibril cross section was monitored.
The advantage is that cross-sectional measurements were
unaffected by fibril length polydispersity. At this point, the
conventional Guinier analysis was no longer valid and the
data were treated by modified Guinier plots as previously
performed for SANS on amyloid-b fibrils (13). The cross-
sectional radius of gyration (Rc) and mass per length (ML)
were obtained from the fits (see Materials and Methods).
Fitting errors (~5%) were the major source of error forML
and taken into consideration. Slight variations in the partial
specific volume (y), which depend on protein type and
folding state (24), can contribute an additional ~3% error.
Including other errors conservatively results in ~10% total
error propagated into the determination ofML, which under-
scores the strength of the technique and allows us to interpret
these values with high confidence. Fig. 2C shows a represen-
tative modified Guinier fit to the SANS curve for 86 min,
where two distinct linear fit regions were observed. The first
one reveals a size of Rc,1¼ 25.65 1.8 A˚ (Qmax$Rc,1¼ 1.31),
which corresponds to growing individual fibrils and closely
matches the TEM-calculated radius. The second linear
region with a larger radius of cross section, Rc,2 ¼ 59.8 5
4.2 A˚ (Qmax$Rc,2¼ 1.18), correlates to fibril bundles formed
by attractive fibril-fibril interactions.Early-stage aggregate structural growth
As stated previously, SANS data for NtQ42P10 early aggre-
gates forming within 71 min were analyzed using Guinier
fits to obtain Rg and M, and we focus on the smaller aggre-
gates having a true Guinier regime. When plotted as a func-
tion of time, Rg,1 and M1 (Fig. 3, A and B) show
a progressive increase in growth. DividingM by the peptide
monomer molecular mass yields the average number of
peptides (n) incorporated into an aggregate species (Fig. 3
B, right axis). We identified the earliest species to have
dimensions intermediate between a dimer and trimer (n ¼
2.6 5 0.4 peptides) having Rg ¼ 16.1 5 5.9 A˚. AlthoughBiophysical Journal 100(10) 2504–2512
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FIGURE 3 Early aggregates of NtQ42P10 formed within the first 71 min.
(A) The smallest species progressively grow from an initial Rg,1 of 16–46 A˚
over this time. (B) The corresponding change in molecular mass with time
for the smaller aggregates, M1 ¼ 22.6 to 123 kDa, with the number of
NtQ42P10 peptides per aggregate, n (right axis) calculated from M1. (C)
A plot of Rg,1 versus M1 compared to model calculations for a random
coil (dashed line) using Eq. 4 and a solid sphere (solid line) using Eq. 5.
(Error bars) Standard error from the Guinier fits.
2508 Stanley et al.no distinct scattering signal from the monomer itself was de-
tected, the HPLC data in Fig. 1 A show the monomer
amount decreased from 60 to 25% over 30–75 min of the
aggregation reaction. Because scattering is weight-aver-
aged, the oligomer scattering signal dominates and obscures
the monomer scattering contribution. For comparison, the
radius of gyration of a monomer with a random coil confor-
mation, Rg,rc, can be predicted from the relation
Rg;rc ¼ 1:98N0:602; (4)
where N ¼ number of residues (25). In our case, the 71-
amino-acid NtQ42P10 has a predicted Rg,rc ¼ 26 A˚, pointingBiophysical Journal 100(10) 2504–2512out that the earliest species we observe here are smaller and
more compact relative to a monomer random coil. These
initial dimer and trimer species grow into oligomers of
n ¼ 14 5 2 peptides with Rg ¼ 46.4 5 4.2 A˚ by 71 min
of the aggregation reaction. It is worth noting that small
mutant Htt oligomers composed of 5–15 proteins recently
have been observed in a HD cell model (26). From a linear
fit to the change in the number of peptides with time (dn/dt),
we found that 6 5 2 peptides/h are incorporated into the
growing oligomers, a rate which then rapidly accelerates
after 56 min.
Again, these growing oligomers are in the presence of
larger structures, which we approximated from Guinier fits
to obtain Rg,2 and M2 (1.46 % Qmax$Rg,2 % 2.21). During
the initial 71 min, Rg,2 increases from 60 to 90 A˚ with
M2z 41 to 370 kDa (nz 5 to 43), respectively. For compar-
ison, TEM on Htt exon 1 Q44 identified 40–50 A˚ diameter
oligomers after 30-min aggregation (27), and AFM on Htt
exon 1 Q53 showed spherical oligomers with diameters of
50–650 A˚ within 1 h with fibrils present by this time (10).
Spherical oligomers of similar size were also observed by
TEM for NtQ30P6 by 15 min of the aggregation reaction
(22). These reported spherical oligomers range from compa-
rable in size up tomuch larger than the oligomerswe detected
by SANS. This is consistent with our analysis that aggregates
larger than the size window of our time-resolved SANS
configuration are simultaneously present.
By plotting Rg versus M (Fig. 3 C) to remove the time
component of growth, correlations between the two param-
eters were discerned. To compare with the experimental
results, two different cases were calculated and plotted: 1),
an equivalent random coil; and 2), a solid sphere. The equiv-
alent random coil Rg,rc was calculated using Eq. 4 with N ¼
M/120.9, where 120.9 Da is the average molecular mass per
residue of NtQ42P10. The solid sphere Rg,sphere was calcu-
lated from M and y ¼ 0.73 mL/g by
Rg;sphere ¼
ﬃﬃﬃ
3
5
r 
3My
4pNA
1=3
: (5)
The initial NtQ42P10 dimer and trimer structures closely
agree with the sphere model M and Rg. Because a sphere
is the shape of minimal volume, this indicates that these
earliest and smallest species are spherical and compact.
As the aggregates become larger in mass and radius, they
slightly diverge from the sphere model but are always
distant from the random coil model. The increasing anisot-
ropy of the aggregates during growth can account for this
divergence from the sphere model.
Although formation of fibrils by monomer addition
driven by aggregation of the polyQ region has been demon-
strated and recognized for some time now (28,29), recent
work by Thakur et al. (22) proposed an aggregation model
where the 17-residue N-terminus of Htt fragments guides
the initial assembly into oligomers. This is consistent with
Huntingtin Aggregates Probed by SANS 2509AFM studies by Legleiter et al. (11) that showed mutant Htt
fragments first form oligomers before fibrils (11). Our
results above on NtQ42P10 illuminate the structural details
of the oligomerization process with evidence for the initial
formation of compact spherical dimers and trimers. These
directly identified, early intermediates progressively grow
in mass and size anisotropy toward becoming predomi-
nantly fibrillar structures. At this point, fibril growth domi-
nates and is now discussed.Later-stage two-dimensional fibril growth
SANS data for NtQ42P10 fibril growth were fit using modi-
fied Guinier plots (see Fig. 2 C) to obtain the Rc and ML as
a function of time (Fig. 4, A and B). Both the single fibril,
with Rc,1 and ML,1, and fibril-fibril aggregates, with Rc,2
and ML,2, were properly treated by modified Guinier anal-
ysis. The open symbols in Fig. 4 Awere from measurements
with aggregate sedimentation, which affected accurate
determination ofML (omitted from Fig. 4, B and C) for these
times but did not appreciably affect Rc,1 and Rc,2 as seen by
their close agreement with the encompassing data. Samples
were redispersed to homogeneity just before measurement
of the last three time points to ensure accurate ML values.
During the time-course for fibrillization, the larger aggre-
gates were about twice the size and mass of the individual
fibrils (Rc,2 z 2Rc,1 and ML,2 z 1.5ML,1), suggesting the
larger aggregates are two aligned and favorably interacting
fibrils.
Single-exponential fits to Rc growth with time (Fig. 4 A)
yield saturating cross-sectional radius of gyration values,
Rc,1(N) ¼ 27.2 5 0.4 A˚ and Rc,2(N) ¼ 635 1 A˚.
Single-exponential fits to the corresponding ML changes
with time (Fig. 4 B) yield reliable rates, kML,1 ¼ 1.5 5
0.2 h1 and kML,2 ¼ 2.1 5 0.3 h1, with saturating mass
per length values, ML,1(N) ¼ 1940 5 30 Da/A˚ and
ML,2(N) ¼ 28805 50 Da/A˚. Most notably, the single fibril
kML,1 closely matches the kinetic rates for monomer loss
(kmon ¼ 1.28 5 0.09 h1) and fibril formation (kfib ¼
1.1 5 0.3 h1) obtained from the HPLC and ThT assays,
respectively. Indeed, the NtQ42P10 aggregation kinetics
describing monomer loss, formation of ThT-positive aggre-
gates, and structural growth in Rc and ML are in agreement
with ~2 h to reach saturation. This importantly demonstrates
that the peptide monomer pool is depleted by about the same
time as structural changes in Rc and ML reach a plateau.
Because SANS is insensitive to the fibril length, it is
unknown from the SANS data alone whether fibril elonga-
tion via monomer addition to the growing fibril-ends
continues well beyond the observed plateau in structural
changes. Monomer loss followed by HPLC confirms this
is not the case.
By plotting Rc,1 versus ML,1 (Fig. 4 C), we removed the
time component to assess how these two parameters are
related for the single NtQ42P10 fibril. For comparison, wecalculated from ML and y ¼ 0.73 mL/g the cross-sectional
radius of gyration for a solid cylinder,
Rc;cyl ¼

MLy
2pNA
1=2
: (6)
We also calculated the cross-sectional radius of gyration for
three hollow cylinder models representing one, two, and
three filaments of the Perutz b-helix model (30) (Fig. 4 D)
from the mass moment of inertia and parallel axis theorem
(see the Supporting Material for derivations):
Rc;f1 ¼

R2i þ R2o
2
1=2
; (7a)

2 2
1=2
Rc;f2 ¼ Ri þ 3Ro ; (7b)

3 15
1=2
Rc;f3 ¼
2
R2i þ 4 R
2
o : (7c)
In the Perutz model, each filament has an internal and
external radius of Ri ¼ 5.9 A˚ and Ro ¼ 15.9 A˚, respectively.
Also, each filament consists of 20 glutamines per 4.75 A˚
b-sheet repeat cross section (30) yielding ML,f1 ¼
538.95 Da/A˚ with ML,f2 ¼ 2ML,f1 and ML,f3 ¼ 3ML,f1.
The discrepancy observed between the experimental data
and the solid cylindrical cross-section model suggests that
the peptide is not optimally packed within the growing
NtQ42P10 fibrils—Rc,1 is always ~1.6Rc,cyl. In fact, we found
excellent agreement with the hollow cylinder models, where
even theML for NtQ42P10 contains an additional 364.5 Da/A˚
compared to the calculated Q20 hollow cylinder ML values
that would make the two- and three-filament models super-
impose with the experimental data. Although this does not
directly prove that NtQ42P10 fibrils are b-helix structures,
the model is consistent with our results. The implications
for the internal fibril structure are discussed below within
the context of the formed mature fibrils.Fibril structure determined from SANS
A more complete scattering vector range (0.004 < Q <
0.18 A˚1) was utilized to carefully probe the final structure
of the NtQ42P10 mature fibrils by SANS (Fig. 5). The fibril
sample prepared at 89 mM was allowed to aggregate
for>500 h at 22C before taking measurements. The result-
ing scattering profile was fit with a long-cylinder form factor
shape (31), which treats the single fibril as a simple cylin-
drical cross section of infinite length to reveal a radius of
475 1 A˚. The observed scattering at Q < 0.02 A˚1 is due
to attractive fibril-fibril interactions, where deviations are
seen between the experimental data and the extrapolated fit.
From the modified Guinier analysis (see Fig. 5, inset),
we found Ic,1(0) ¼ 0.00308 5 (9  105) A˚1 cm1 and
Rc,1 ¼ 33 5 1 A˚ (Qmax$Rc,1 ¼ 1.55), which yieldedBiophysical Journal 100(10) 2504–2512
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FIGURE 4 Aggregates of NtQ42P10 beyond 1 h are predominately
fibrillar and their two-dimensional cross section is analyzed. (A) Change
in the two characteristic length-scales, Rc,1 (circles) and Rc,2 (triangles),
with time. (Open symbols) Rc measurements where sample sedimentation
was observed. (Solid lines) Single-exponential fits to the data. (B) Corre-
sponding changes in ML,1 (circles) and ML,2 (triangles). (Solid lines)
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FIGURE 5 SANS data obtained over a larger Q-range allow the
NtQ42P10 fibril structure to be more carefully probed. Peptide concentration
was 89 mM. A long-cylinder form factor fit (solid line) accounts for the
SANS profile at high and intermediate Q values. Deviations observed
between the experimental scattering data and the extrapolated fit (dashed
line) at Q < 0.02 A˚1 are due to favorable fibril-fibril interactions. The
modified Guinier plot of the SANS profile (inset) shows two linear fit
regions, denoted as 1 and 2, with the resulting Rc and ML values given in
the text. (Error bars) Standard errors from the radial average of the intensity
data on the neutron area detector.
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ﬃﬃﬃ
2
p
Rc;1 ¼ R1 ¼ 47 5 1 A˚,
respectively. The obtained fibril radius R1 matches
both the cylinder form factor fit radius and the average
single fibril radius determined by TEM (R ¼ 40 5 8 A˚).
Also, from the modified Guinier analysis, we found
Ic,2(0) ¼ 0.0057 5 (3  104) A˚1 cm1, which yielded
ML,2 ¼ 3300 5 200 Da/A˚, and Rc,2 ¼ 77 5 4 A˚
(Qmax$Rc,2 ¼ 1.17). All of these values are also comparable
to those from the NtQ42P10 kinetic end-state fibrils, demon-
strating reproducibility.
Measurements of both the NtQ42P10 fibril radius and mass
per length provide constraints on the internal structural
arrangements of the peptides within the fibril. Thus, to
determine the number of peptides per fibril, we constructed
a simple volume element to describe the fibril cross section
and compare the maximum and actual number of peptides
filling this volume. With a b-sheet structure having
a 4.75 A˚ repeat distance and the peptide chains orientedSingle-exponential fits to the data. (C) A plot of Rc,1 versus ML,1 compared
to model calculations for a solid cylinder cross section (solid line) using
Eq. 6 and the Perutz hollow cylinder b-helix cross section for one, two,
and three filaments per fibril (numbered squares) using Eqs. 7a, 7b, and
7c, respectively. (Dashed line) Guide to the eye. The corresponding points
to the open-symbol data in panel A are omitted from panels B and C,
because sample sedimentation influencedML values. (Error bars) Standard
error from the modified Guinier fits. (D) Schematics of the hollow cylinder
models for one, two, and three filaments per fibril used to calculate Rc in
panel C. The inner and outer radii of a single filament, Ri and Ro, respec-
tively, are indicated on model 1.
Huntingtin Aggregates Probed by SANS 2511normal to the fibril direction, we calculated the maximum
number of peptides per b-sheet repeat distance (nL,max)
from the fibril radius as
nL;max ¼ pR
2LNA
y Mpep
; (8)
where L ¼ 4.75 A˚, y ¼ 0.73 mL/g, and Mpep ¼ peptide
molecular mass (¼ 8583 Da). The actual number of peptides
per 4.75 A˚ (nL) was directly calculated from ML,
nL ¼ MLL
Mpep
: (9)
Interestingly, the mature fibrils have three times less
peptide than expected for a laminated b-sheet structure
with nL,max ¼ 3.2 5 0.1 peptides and nL ¼ 1.00 5 0.03
peptides. From the time-resolved SANS data with a satu-
rating radius R1(N) ¼ 38.5 5 0.6 A˚ and mass per length
ML,1(N) ¼ 1940 5 30 Da/A˚, we found nL,max ¼ 2.13 5
0.07 and actual nL ¼ 1.075 0.02, respectively. Again, our
results are quantitatively consistent with the Perutz b-helix
structural model. Because 40 glutamines are required to
stabilize the b-helix structure with two full turns to form
a filament (30), only 0.5 peptide/4.75 A˚ for NtQ42P10 is
needed. Thus, a single fibril of 2–3 filaments would have
1–1.5 peptides/4.75 A˚. In addition, the hollow cylinder
models above have Rc,f2 ¼ 28 A˚ and Rc,f3 ¼ 32 A˚, values
matching the measured fibril Rc,1. Extending the idea of
2–3 filaments composing a single fibril, we noted the
smallest detected species are dimers and trimers and could
serve as the basic building blocks for the growing fibrils,
although this could be fortuitous.
Evidence against the b-helix model for polyQ has been
reported (32,33). However, we emphasize that the sequence
context of NtQ42P10 appears to play an important role in the
resulting fibril structure. Also, polymorphisms in fibril
structure are a common characteristic, as demonstrated for
amyloid-b (34). Different peptide concentrations and
growth conditions can result in structural variations and if
any structural heterogeneity is present, SANS will give an
average structure. One consideration that may help to satisfy
both Rc and ML values is that either or both the 17-residue
N-terminal and P10 regions of NtQ42P10 maintain extended
or disordered conformations whereas the Q42 region forms
the b-sheet core of the fibril.
X-ray crystallography experiments on Htt exon 1 Q17
show the N-terminal region is capable of adopting an a-
helix conformation whereas the proline-rich C-terminus
forms a polyproline helix (35). X-ray fiber diffraction on
Htt exon 1 Q51 also suggests that the flanking polyproline
region is not part of the ordered fibril structure (36). Our
results on NtQ42P10 fibrils underscore the need to further
investigate the effects of sequence context, polyQ length,
and growth conditions on Htt fibrils. More detailed knowl-edge concerning the fibrils would aid in determining the
aggregation pathways undertaken by monomeric and oligo-
meric species to construct the resulting fibrils.CONCLUSIONS
With time-resolved SANS, we are capable of pinpointing
and characterizing the smallest of mutant Htt species as
they exist in solution at a given time during the aggregation
process. These species can be distinguished from the pres-
ence of the larger aggregates that are simultaneously
present. Our results provide a detailed view where aggrega-
tion of the mutant Htt exon 1 peptide, NtQ42P10, begins with
compact spherical dimers and trimers coexisting with larger,
quickly forming oligomer species. Monomer depletion and
ThT-positive aggregate formation ensues with no observed
lag phase. The dimers and trimers grow into 14-mers within
71 min, which matches the 5- to 15-mer oligomers recently
observed in a HD cell model (26).
Beyond this point, the aggregates in solution become
predominately fibrillar. The late-stage fibrillization process
reaches a plateau in cross-sectional radius and mass per
length within ~2 h, concurrent with full monomer depletion
and saturation of ThT-positive aggregate development.
These formed fibrils are amyloidlike but interestingly, the
peptide is assembled within these fibrils at only ~31–50%
of the capable packing efficiency. This packing arrangement
is quantitatively consistent with the Perutz b-helix structural
model as opposed to any compact b-sheet-rich structural
arrangements (32,33,37).
The detailed structural information provided here for the
early-stage oligomers, forming fibrils, and end-state fibrils
should be of great value in more carefully discerning their
respective structures and roles in the aggregation pathway.
Implications for the toxicity of early oligomers to neuronal
cells now can be discussed within the context of the struc-
tural details we provide. This time-resolved SANS approach
to capture the structures of transient amyloidlike aggregates
in solution establishes a strong method that should prove
useful in the further study of aggregates pertaining to HD
as well as the study of other protein aggregation processes
like those involved in Alzheimer’s and Parkinson’s diseases.SUPPORTING MATERIAL
Additional information regarding Eqs. 7a–7c is available at http://www.
biophysj.org/biophysj/supplemental/S0006-3495(11)00465-6.
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